Dow AgroSciences and Synthace Collaborate Using Antha
- Posted on 1 October, 2015
Synthace and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), today announce they have entered into a research collaboration to optimise technology by accelerating development of fermentation-based production of crop protection products.
The collaboration includes a multi-seat enterprise license giving Dow AgroSciences access to Synthace’s Antha software tools. As part of the agreement, Synthace’s advanced tools and software will be used to support development of superior microbial production strains at Dow AgroSciences. This collaboration brings together expertise in natural products from both companies to enable new approaches for accelerated product development.
This collaboration supports the ability of Dow AgroSciences to use the power of nature in conjunction with fermentation technology, to produce and develop solutions for farmers. These types of products prevent pest infestation and control disease to increase crop yields. Applying automated strain engineering enables quicker development of new microbial production hosts in the lab which can expedite development of fermentation processes for new products. Farmers win as new solutions can be brought to market more quickly. Dr. Tim Fell, Chief Executive Officer of Synthace, commented, “Antha is a platform that links research, development and biomanufacturing. We look forward to employing it with Dow AgroSciences to optimize tools and processes that enable them to continue to boost bottom-line performance.”
“It is important for Dow AgroSciences to bring new products to farmers faster and this collaboration on strain engineering will accelerate our ability to create novel microbial production strains,” said Dr. Nigel J. Mouncey, Bioengineering and Bioprocessing R&D Director, Dow AgroSciences. “Working with Synthace gives us the ability to achieve our goals more quickly in an expanded and automated manner via their innovative technologies.”
Synthace engineers biology for applications across health, food, energy and manufacturing. Combining computation, biology and automation the company rapidly develops robust, high yielding bioprocesses to make bio-based products with strategic partners. Central to Synthace’s technology is Antha, a platform that brings quality by design and design for manufacturing to biological research and development. Learn more at www.synthace.com and www.antha.com.
About Dow AgroSciences
Dow AgroSciences discovers, develops, and brings to market crop protection and plant biotechnology solutions for the growing world. Based in Indianapolis, Indiana, USA, Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $7.3 billion in 2014. Learn more at www.dowagro.com. Follow Dow AgroSciences on Facebook, Twitter, LinkedIn, and Google+, or subscribe to our News Release RSS Feed.
+44 20 3642 1350
Share this article:
People also read
Book before March 29th to receive 20% discount*
Building a multibillion-dollar synthetic biology industry The Synthetic Biology conference taking place in 2019, in London, that is not to be missed....
Evonetix establishes scientific advisory board
CAMBRIDGE, UK, 20 December 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fideli...
Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution
Colorifix, a company that has developed the first commercial biological dyeing process, has raised a Series A round of $3 million from impact and stra...